Related Experiment Video
Updated: Mar 26, 2026

Investigating Aortic Valve Calcification via Isolation and Culture of T Lymphocytes using Feeder Cells from Irradiated Buffy Coat
Published on: February 4, 2021
Targeting local vascular and systemic consequences of inflammation on vascular and cardiac valve calcification
Lucie Hénaut1, Maria Dolores Sanchez-Nino2,3, Gonzalo Aldamiz-Echevarría Castillo4
1a 1 Universidad Autónoma de Madrid, School of Medicine, Nephrology, IIS-Fundación Jiménez Díaz , Madrid, Spain.
Insights
Inflammation accelerates vascular calcification (VC), a risk factor for cardiovascular mortality. Understanding this link may lead to new treatments for VC, especially in patients with chronic kidney disease.
Area of Science:
- Cardiovascular Research
- Nephrology
- Inflammation Biology
Background:
- Vascular calcification (VC) is linked to cardiovascular mortality in the general population and chronic kidney disease (CKD) patients.
- Systemic inflammation, driven by conditions like CKD and diabetes, is associated with VC.
Purpose of the Study:
- To review evidence linking inflammation to the progression of vascular calcification.
- To explore the molecular mechanisms by which inflammation affects VC.
Main Methods:
- Collated clinical and experimental evidence on inflammation's role in VC.
- Reviewed the impact of pro-inflammatory cytokines (e.g., TNF, IL-6) and transcription factors (e.g., NF-κB) on VC.
- Examined the influence of senescence and circulating factors (Fetuin A, Klotho) in inflammation-driven VC.
Main Results:
- Inflammatory cytokines and NF-κB directly promote calcification in cellular and animal models.
- Inflammation can indirectly accelerate VC by reducing protective factors like Fetuin A and Klotho.
- Experimental data suggests a causal relationship between inflammation and VC progression.
Conclusions:
- A causal link between inflammation and VC suggests potential shifts in clinical prevention and treatment strategies.
- The precise molecular mechanisms underlying inflammation-induced VC require further elucidation.
- Further research is needed on the effects of anti-inflammatory biologics and dietary phosphate on VC in specific patient populations.
Introduction:
Cardiac valve calcification and vascular calcification (VC) are associated with cardiovascular mortality in the general population and in patients with chronic kidney disease (CKD). CKD, diabetes mellitus, and atherosclerosis are among the causes of systemic inflammation that are associated with VC.
Areas Covered:
This review collates clinical and experimental evidence that inflammation accelerates VC progression. Specifically, we review the actions of key pro-inflammatory cytokines and inflammation-related transcription factors on VC, and the role played by senescence. Inflammatory cytokines, such as the TNF superfamily and IL-6 superfamily, and inflammation-related transcription factor NF-κB promote calcification in cultured vascular smooth muscle cells, valvular interstitial cells, or experimental animal models through direct effects, but also indirectly by decreasing circulating Fetuin A or Klotho levels.
Expert Opinion:
Experimental evidence suggests a causal link between inflammation and VC that would change the clinical approach to prevention and treatment of VC. However, the molecular basis remains unclear and little is known about VC in humans treated with drugs targeting inflammatory cytokines. The effect of biologicals targeting TNF-α, RANKL, IL-6, and other inflammatory mediators on VC, in addition to the impact of dietary phosphate in patients with chronic systemic inflammation, requires study.
Related Concept Videos
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT
Rheumatic Heart Disease I: Introduction
Myocarditis I: Introduction
Coronary Artery Disease II: Pathophysiology

